Alken Fund Absolute Return Europe CH3 CHF/  LU1040153956  /

Objectives and Investment Policy: We aim to provide you with annual positive returns, whatever the prevailing market and economic conditions are. A positive return may not be achieved at all times. We take investment decisions on the basis of our analysis of companies' financial figures and management conditions. This analysis allows us to buy companies that are likely to experience an increase in their value or companies whose share price is undervalued in comparison to their intrinsic value. We sell companies that are likely to experience a decrease in their price. The Sub-Fund will be exposed (through investments or cash) to other currencies then the base currency. The Sub-Fund may use complex financial instruments ("derivatives") such as futures, options, forwards and swaps to optimise the management of your portfolio or protect its value against adverse movements in financial markets. In order to optimise the management of your portfolio or protect its value against adverse movements in financial markets we may use non exchange traded financial contracts such as Contracts for Difference (CFD). A derivative is a financial instrument which derives its value from the value of an underlying asset. The use of derivative is not cost or risk-free. Benchmark: The Sub-Fund is actively managed without reference to a benchmark. Intended retail investor: Suitable for investors with all levels of knowledge and/or experience, seeking capital growth and who have a 5 years investment horizon. The product does not have any capital guarantee and up to 100% of their capital is at risk.

Objectives and Investment Policy: We aim to provide you with annual positive returns, whatever the prevailing market and economic conditions are. A positive return may not be achieved at all times. We take investment decisions on the basis of our analysis of companies' financial figures and management conditions. This analysis allows us to buy companies that are likely to experience an increase in their value or companies whose share price is undervalued in comparison to their intrinsic value. We sell companies that are likely to experience a decrease in their price.